Description
MOD TO DECREASE FUNDING PATHOLOGY TESTING
Base award description: IGF::OT::IGF PATHOLOGY TESTING
Modification chain · 10 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2015-11-03+$214,517= $214,517
- Mod P000012016-08-25-$45,000= $169,517
- Mod P000022016-10-01+$211,758= $381,275
- Mod P000032017-11-30+$211,758= $593,033
- Mod P000042018-01-09+$1,537= $594,570
- Mod P000052018-06-26+$5,000= $599,570
- Mod P000062018-10-01+$215,112= $814,682
- Mod P000072019-11-25+$107,016= $921,698
- Mod P000082020-03-05-$18,716= $902,982
- Mod P000092021-02-19-$15,339= $887,643
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2015-11-03 | +$214,517 | $214,517 | IGF::OT::IGF PATHOLOGY TESTING |
| Mod P00001· FUNDING ONLY ACTION | 2016-08-25 | −$45,000 | $169,517 | IGF::OT::IGF PATHOLOGY TESTING |
| Mod P00002· EXERCISE AN OPTION | 2016-10-01 | +$211,758 | $381,275 | IGF::OT::IGF PATHOLOGY TESTING |
| Mod P00003· EXERCISE AN OPTION | 2017-11-30 | +$211,758 | $593,033 | IGF::OT::IGF PATHOLOGY TESTING |
| Mod P00004· FUNDING ONLY ACTION | 2018-01-09 | +$1,537 | $594,570 | IGF::OT::IGF PATHOLOGY TESTING |
| Mod P00005· FUNDING ONLY ACTION | 2018-06-26 | +$5,000 | $599,570 | IGF::OT::IGF PATHOLOGY TESTING |
| Mod P00006· EXERCISE AN OPTION | 2018-10-01 | +$215,112 | $814,682 | IGF::OT::IGF PATHOLOGY TESTING |
| Mod P00007· CHANGE ORDER | 2019-11-25 | +$107,016 | $921,698 | PATHOLOGY TESTING |
| Mod P00008· CHANGE ORDER | 2020-03-05 | −$18,716 | $902,982 | PATHOLOGY TESTING |
| Mod P00009· FUNDING ONLY ACTION | 2021-02-19 | −$15,339 | $887,643 | MOD TO DECREASE FUNDING PATHOLOGY TESTING |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI JA87HT8KP2M2)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25526N0379 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES | $671,956 | FY2026 |
| 36C25626P0989 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES | $24,200 | FY2026 |
| 36C24126N0746 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $2,961 | FY2026 |
| 36C24126N0753 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $89,895 | FY2026 |
| 36C24126N0747 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $127,637 | FY2026 |
| 36C24126N0748 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $13,031 | FY2026 |
Other recipients under Q515 from 250-NETWORK CONTRACT OFFICE 10 (36C250) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C25026D0050 | REGENTS OF THE UNIVERSITY OF MICHIGAN | 250-NETWORK CONTRACT OFFICE 10 (36C250) | $0 | FY2026 |
| 36C25026N0802 | REGENTS OF THE UNIVERSITY OF MICHIGAN | 250-NETWORK CONTRACT OFFICE 10 (36C250) | $105,506 | FY2026 |
| 36C25026N0489 | INDIANA UNIVERSITY HEALTH CARE ASSOCIATES, INC. | 250-NETWORK CONTRACT OFFICE 10 (36C250) | $583,647 | FY2026 |
| 36C25026P0455 | THE CLEVELAND CLINIC FOUNDATION | 250-NETWORK CONTRACT OFFICE 10 (36C250) | $134,495 | FY2026 |
| 36C25025N0773 | GHOST RX INC. | 250-NETWORK CONTRACT OFFICE 10 (36C250) | $130,000 | FY2025 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA25016F0001_3600_V797D30108_3600 · retrieved 2026-09-26.